When was Mauna Kea Tech founded?

Mauna Kea Tech was founded in 2000 and raised its 1st funding round 8 years after it was founded.

Where is Mauna Kea Tech located?

Mauna Kea Tech is headquartered in Paris, France. It is registered at Šlechtitelů 813 77900 Olomouc.

How many employees does Mauna Kea Tech have?

As of Sep 30, 2026, the latest employee count at Mauna Kea Tech is 122.

Is Mauna Kea Tech a funded company?

Mauna Kea Tech is a funded company, having raised a total of $30M across 7 funding rounds to date. The company's 1st funding round was a $***** Series C round, raised on Jan 23, 2008.

When was the latest funding round of Mauna Kea Tech?

Mauna Kea Tech's latest funding was a $***** Post IPO round on Nov 13, 2023, with participation from 1 investor. Its primary sector is Gastroenterology. In France, the Gastroenterology sector has seen $165M in funding in 2026 to date.

Where does Mauna Kea Tech rank among its competitors?

Mauna Kea Tech ranks 1st amongst 50 active competitors, of which 13 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was ClimateWell, which secured $10M in Jan, 2026.

Who are the top competitors of Mauna Kea Tech?

Mauna Kea Tech's top competitors include CapsoVision, EchoSens and Diversatek Healthcare. Among them, ClimateWell secured the most recent funding round in January, 2026.

Mauna Kea Tech - 2026 Company Profile, Team, Funding & Competitors

Company Details

Mauna Kea Technologies produces devices for microscopic imaging during endoscopy procedures. Its tools allow surgeons to visualize, take biopsies, detect or rule out malignant or pre-malignant tumors or lesions in the gastrointestinal tract and pulmonary tracts. Their flagship product, Cellvizio, is a probe-based Confocal Laser Endomicroscopy (pCLE) system, that provides real-time access to histological images during standard endoscopy procedures through high-resolution cellular imaging of internal tissues. Cellvizio is cleared by FDA and has the European CE-Mark for use during digestive, pulmonary and urinary endoscopy procedures, including pancreatic and biliary endoscopic explorations as well as fine needle aspiration procedures. Mauna Kea Technologies also obtained clearance in China and Japan. Cellvizio went public in July 2011 and trades on the NYSE Euronext exchange.

Website: www.maunakeatech.com/
Social
Email ID: *****@maunakeatech.com
Registered Address: Šlechtitelů 813 77900 Olomouc

Key Metrics

Founded Year

2000

Location

Paris, France

Stage

Public

Total Funding

$30M in 7 rounds

Latest Funding Round

Post IPO, Nov 13, 2023, $*****

Investors

IPF Partners & 8 more

Ranked

1^st among 50 active competitors

Employee Count

122 as on Sep 30, 2026

Similar Companies

CapsoVision & 43 more

Exit Details

Public

View Mauna Kea Tech's full profile

Mauna Kea Tech is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Mauna Kea s.r.o. CIN: 29357527 , Czech Republic, Active	May 29, 2012	-	-

Mauna Kea Tech got listed on Aug 08, 2023.

Click here to take a look at Mauna Kea Tech's IPO in detail

Mauna Kea Tech has raised a total funding of $30M over 7 rounds. Its first funding round was on Jan 23, 2008. Its latest funding round was a Post IPO round on Nov 13, 2023 for $*****. 1 investor participated in its latest round. Mauna Kea Tech has 9 institutional investors.

Here is the list of recent funding rounds of Mauna Kea Tech:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 13, 2023	2680455	Post IPO	9023919	4894549	2175390	1232893
Dec 16, 2019	3351869	Post IPO	7744805	9610059	7422292	Johnson & Johnson Innovation
Jul 03, 2019	5866592	Conventional Debt	3393014	5788541	8079483	European Investment Bank

Access funding benchmarks and valuations. Sign up today!

View details of Mauna Kea Tech's funding rounds and investors

The founders of Mauna Kea Tech is Sacha Loseau.

Here are the details of Mauna Kea Tech's key team members:

Sacha Loseau: Founder of Mauna Kea Tech.

View details of Mauna Kea Tech's Founder profiles and Board Members

Mauna Kea Tech's employee count trend

Mauna Kea Tech has 122 employees as of Sep 26. Here is Mauna Kea Tech's employee count trend over the years:

Uncover Mauna Kea Tech's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Mauna Kea Tech include CapsoVision, EchoSens and Diversatek Healthcare. Here is the list of Top 10 competitors of Mauna Kea Tech, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Mauna Kea Tech 2000, Paris (France), Public	Endomicroscopy devices for Gastrointestinal and Respiratory tracts	$30M	IPF Partners, European Investment Bank & 7 others	61/100
2nd	CapsoVision 2006, Saratoga (United States), Public	GI capsule imaging system	$118M	-	61/100
3rd	EchoSens 2001, Paris (France), Acquired	Developer of non-invasive diagnostics products for the detection of liver disease	$32.7M	Orbimed, Cathay Capital & 4 others	52/100
4th	Diversatek Healthcare 2017, Milwaukee (United States), Unfunded	A portfolio of Gastroenterological therapeutics and diagnostics devices	-	-	48/100
5th	OutSense Diagnostics 2016, Or Yehuda (Israel), Series A	Provider of AI-powered IoT devices for diagnostics	$2.7M	EIC Fund, Incentive Incubator & 3 others	43/100
6th	Anhan Medical 2009, Wuhan (China), Series C	A capsule endoscopic robotic system for the early detection of gastrointestinal disease	$115M	SBCVC, PreIPO Capital & 4 others	42/100
7th	Invendo Medical 2007, Garden City (United States), Acquired	Single-use medical devices improving patient care in endoscopy, anesthesia, and monitoring	$28M	TVM Capital Life Science, 360 Capital Partners ... & 3 others	41/100
8th	AnX Robotics 2019, Plano (United States), Unfunded	Manufacturer of capsule endoscopy systems and gastrointestinal diagnostic medical devices	-	-	40/100
9th	ClimateWell New York City (United States), Seed	Developer of a respiratory device designed to improve lung health	$10M	Lerer Hippeau, Cade Venture & 4 others	39/100
10th	Avantis 2004, Sunnyvale (United States), Deadpooled	Visualization technology for detection and prevention of GI cancers	$62.5M	Mitsubishi Corporation, Montreux Equity Partners ... & 6 others	36/100